SCHEMBL21067463

SCHEMBL21067463

CC(C)(C)c1cc(N=Nc2ccccc2C(=O)O)ccc1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.64
KMT2A Q03164 7/20 0.64
MAPT P10636 6/20 0.64
NPSR1 Q6W5P4 3/20 0.64
GAA P10253 2/20 0.64
L3MBTL1 Q9Y468 2/20 0.64
IDE P14735 1/20 0.58
MYC P01106 1/20 0.53
THRB P10828 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
PSMD14 O00487 1/20 0.52
HSP90AA1 P07900 1/20 0.52
MMP2 P08253 1/20 0.52
MAPK1 P28482 1/20 0.52
PDE4A P27815 1/20 0.50
BLVRB P30043 1/20 0.50
KDR P35968 1/20 0.50
HTT P42858 1/20 0.50
APP P05067 1/20 0.46
RECQL P46063 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29377614 0.83 MEN1 (0.74) MEN1KMT2AMAPTNPSR1GAA
SCHEMBL25270006 0.83 MEN1 (0.74) MEN1KMT2AMAPTNPSR1GAA
SCHEMBL21067788 0.82 KMT2A (0.69) MEN1KMT2AMAPTNPSR1GAA
SCHEMBL6812002 0.76 MEN1 (0.62) MEN1KMT2AMAPTNPSR1GAA
SCHEMBL21067348 0.76 KMT2A (0.71) MEN1KMT2AMAPTNPSR1GAA
SCHEMBL29021820 0.75 MAPT (0.67) MEN1KMT2AMAPTNPSR1GAA
SCHEMBL6812006 0.75 MEN1 (0.60) MEN1KMT2AMAPTNPSR1GAA
SCHEMBL6812010 0.75 MEN1 (0.60) MEN1KMT2AMAPTNPSR1GAA
SCHEMBL6807306 0.75 MEN1 (0.60) MEN1KMT2AMAPTNPSR1GAA
SCHEMBL6807307 0.75 MEN1 (0.60) MEN1KMT2AMAPTNPSR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed